TIME FROM FIRST SYMPTOM TO TREATMENT ONSET IN LUNG CANCER PATIENTS- RESULTS FROM A GREEK REGISTRY
Author(s)
Kourlaba G1, Gkiozos I2, Stefanou G3, Kokkotou E4, Maniadakis N5, Syrigos K2
1National School of Public Health, Athens, HI, Greece, 23rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, National & Kapodistrian University, Athens, Greece, 3National School of Public Health, Athens, A1, Greece, 43rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, National & Kapodistrian University, Athens, A1, Greece, 5National School οf Public Health, Athens, Greece
OBJECTIVES: : To map the patients’ journey from first symptom presentation to treatment initiation for the most frequent histological types of lung cancer in Greece. METHODS: The primary data source was a hospital-based registry of all new lung cancer cases who took care in the Oncology Unit of “Sotiria” Hospital, in Athens, in Greece from the year 2015 and onward. Demographic, anthropometric and lifestyle characteristics, medical history, diagnostic-related characteristics and treatment related data were extracted from registry for patients diagnosed with Adenocarcinoma, Squamous Cell Carcinoma and Small Cell Lung Cancer. The time intervals from 1st symptom to diagnosis (StD), diagnosis to treatment initiation (DtT), and surgery to post–surgery treatment (SRGtT) were calculated. RESULTS: CONCLUSIONS: Our results indicate that strategies to expedite lung cancer diagnosis and access to evidence-based treatment in Greece are required, since these patients experience substantial delays from first symptoms presentation to treatment initiation.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PCN13
Topic
Epidemiology & Public Health
Topic Subcategory
Disease Classification & Coding
Disease
Oncology